New hope for tough leukemia: tiny fat bubbles deliver targeted therapy
Disease control
Recruiting now
This early-phase study tests a new drug called C6 ceramide NanoLiposome (CNL) in 15 adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. Researchers will also watch…
Phase: PHASE1 • Sponsor: Keystone Nano, Inc • Aim: Disease control
Last updated May 07, 2026 18:41 UTC